Boston Scientific Corp logo

Boston Scientific Corp BSX

Market Closed
14 Jun, 20:00
NYSE NYSE
$
76. 76
-0.2
-0.26%
After Hours
$
76. 77
+0.01 +0.01%
113.15B Market Cap
74.55 P/E Ratio
0% Div Yield
3,540,300 Volume
2.01 Eps
$ 76.96
Previous Close
Day Range
76.43 77.03
Year Range
48.35 77.64

BSX Chart

Boston Scientific Corp Profile

Medical Devices Industry
Healthcare Sector
Mr. Michael F. Mahoney CEO
NYSE Exchange
US1011371077 ISIN
US Country
48,000 Employees
- Last Dividend
6 Nov 2003 Last Split
18 May 1992 IPO Date

Overview

Boston Scientific Corporation is a global developer, manufacturer, and marketer of medical devices used in a variety of interventional medical specialties. Having begun its operations in 1979, the company has grown to serve a diverse range of medical needs through its two primary segments: MedSurg and Cardiovascular. With its headquarters in Marlborough, Massachusetts, Boston Scientific is committed to improving patient health by providing cutting-edge solutions that address complex medical conditions and enhance the quality of life for patients worldwide.

Products and Services

  • Gastrointestinal and Pulmonary Devices: These include resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes. These devices are aimed at diagnosing and treating conditions within the gastrointestinal and pulmonary systems, offering advanced options for physicians and improved care for patients.
  • Urology Devices: Comprising ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincters, lasers, fibers, and hydrogel systems. These products target urological conditions, providing solutions that maintain urinary function and patient quality of life.
  • Neurology and Pain Management Devices: This category includes spinal cord stimulator systems, proprietary programming software, radiofrequency generators, indirect decompression systems, practice optimization tools, and deep brain stimulation systems. Designed for treating neurological movement disorders and chronic pain management, these devices help patients return to their normal activities with less discomfort.
  • Cardiovascular Technologies: Offering technologies for diagnosing and treating coronary artery disease and aortic valve conditions, including WATCHMAN FLX Left Atrial Appendage Closure Device. Boston Scientific focuses on delivering innovative solutions for heart diseases, aiming to improve patient outcomes and reduce healthcare costs.
  • Electrophysiology Devices: Including cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. These products are designed for the diagnosis and treatment of rate and rhythm disorders of the heart, enhancing life quality for patients with heart conditions.
  • Diseases of the Peripheral System: Devices targeting peripheral arterial and venous diseases, providing diagnostic and therapeutic options for patients suffering from these circulatory conditions.
  • Cancer Diagnosis and Treatment: Offering products that facilitate the diagnosis, treatment, and palliation of various forms of cancer, Boston Scientific aims to contribute to the overall cancer care continuum, from early detection to treatment and beyond.

Contact Information

Address: 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234
Phone: 508 683 4000